| ACE2 | angiotensin-converting enzyme 2 |
| ADMET | Absorption, Distribution, Metabolism, Elimination and Toxicity |
| ARA | angiotensin receptor antagonist |
| ARB | angiotensin receptor blockers |
| CD | connector domain |
| CH | central helix |
| COVID-19 | coronavirus disease 2019 |
| CT | cytoplasmic tail |
| DHA | Docosahexaenoic acid |
| FDA | Food and Drug Administration |
| FP | fusion peptide |
| HR1 | heptad repeat 1 |
| HR2 | heptad repeat 2 |
| NTD | followed by an N-terminal domain |
| RBD | receptor-binding domain |
| RBM | receptor binding motif |
| SS | signal peptide |
| TM | transmembrane domain |
| WHO | World Health Organization |